Lps binding protein (LBP) function in germfree mice

Journal of Endotoxin Research

Volumn 4, Issue 3, 1997, Pages 183-187

  Le Roy, D ^a   Glauser, M P ^a   Heumann, D ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; BINDING PROTEIN; ENDOTOXIN; GALACTOSAMINE;

ACUTE PHASE RESPONSE; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; ENDOTOXEMIA; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MONOCYTE; MOUSE; NONHUMAN;

ANIMALIA; BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA;

EID: 0030738286     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/096805199700400303     Document Type: Article

References (24)

1. Ulevitch R.J., Tobias P.S. Recognition of endotoxin by cells leading to transmembrane signaling. Curr Biol 1994; 6: 125-130.
2. Heumann D., Gallay P., Barras C. et al. Control of LPS binding and LPS-induced TNF secretion in human peripheral blood monocytes. J Immunol 1992; 148: 3505-3512.
3. Schumann R.R., Leong S.R., Flaggs G.W. et al. Structure and function of lipopolysaccharide binding protein. Science 1990; 249: 1429-1431.
4. Gallay P., Heumann D., Le Roy D., Barras C., Glauser M.P. Lipopolysaccharide-binding protein as a major plasma protein responsible for endotoxemic shock. Proc Natl Acad Sci USA 1993; 90: 9935-9938.
5. Gallay P., Heumann D., Le Roy D., Barras C., Glauser M.P. Mode of action of anti-lipopolysaccharide binding protein (LBP) antibodies for prevention of endotoxemic shock in mice. Proc Natl Acad Sci USA 1994; 91: 7922-7926.
6. Landy M., Whitby J.L., Michael G., Woods M.W., Newton W.L. Effects of bacterial endotoxin in germ-free mice. Proc Soc Exp Biol Med 1962; 109: 352-356.
7. Jensen S.B., Mergenhagen S.E., Fitzgerald R.J., Jordan H.V. Susceptibility of conventional and germfree mice to lethal effects of endotoxin. Proc Soc Exp Biol Med 1963; 113: 710-714.
8. Matsuzawa X, Wilson R. Oxygen changes in tissue of germfree and conventional mice after inoculation of endotoxin. Tohoku J Exp Med 1965; 85: 361-364.
9. Lengacher S., Jongeneel C.V., Le Roy D. et al. Reactivity of murine and human recombinant LPS-binding protein (LBP) with LPS and Gram negative bacteria. J Inflamm 1996; 47: 165-172.
10. Gallay P., Jongeneel C.V., Barras C. et al. Short-time exposure to LPS is sufficient to activate human monocytes. J Immunol 1993; 150: 5086-5093.
11. Gallay P., Barras C., Tobias P.S., Calandra T., Glauser M.P., Heumann D. Lipopolysaccharide (LPS)-binding protein in human serum determines the tumor necrosis factor response of monocytes to LPS. J Infect Dis 1994; 170: 1319-1322.
12. Gallay P., Carrel S., Glauser M.P. et al. Purification and characterization of murine LPS binding protein. Infect Immun 1993; 61: 378-383.
13. Baumgartner J.D., Heumann D., Gerain J., Weinbreck P., Grau G.E., Glauser M.P. Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor a and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies. J Exp Med 1990; 171: 889-896.
14. Pugin J., Heumann D., Tomasz A. et al. CD14 is a pattern recognition receptor. Immunity 1994; 1: 509-516.
15. Nicaise P., Gleizes A., Forestier E, Sandre C., Querb A.M., Labarre, C. The influence of E. coli implantation in axenic mice on cytokine production by peritoneal and bone marrow-derived macrophages. Cytokine 1995; 7: 713-719.
16. Nicaise P., Gleizes A., Forestier F., Quéro A.M., Labarre C. Influence of intestinal bacterial flora on cytokines (IL-1, IL-6 and TNFα) production by mouse peritoneal macrophages. Eur Cytokine Netw 1993; 4: 133-138.
17. Bellezzo J.M., Britton R.S., Bacon B.R., Fox, E.S. LPS-mediated NF-κB activation in rat Kupffer cells can be induced independently of CD14. Am J Physiol 1996; 270: G956-G961.
18. Lynn WA, Liu Y., Golenbock D.T. Neither CD14 nor serum is absolutely necessary for activation of mononuclear phagocytes by bacterial lipopolysaccharide. Infect Immun 1993; 61: 4452-4461.
19. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433.
20. Hirohashi N., Richards M., Morrison D.C. Selective effects of serum on bacterial LPS-induced IL-6 and nitric oxide production in murine macrophages. J Endotoxin Res 1996; 3: 395-405.
21. Lehmann V., Freudenberg M.A., Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med 1987; 165: 657-663.
22. Asari Y., Majima M, Sugimoto K., Katori M., Ohwada T. Release site of TNFα after intravenous and intraperitoneal injection of IPS from Escherichia coli in rats. Shock 1996; 5: 208-212.
23. Kumins N.H., Hunt J., Gamelli R.L., Filkins J.P. Partial hepatectomy reduces the endotoxin induced peak circulating level of tumor necrosis factor in rats. Shock 1996; 5: 385-388.
24. Grube B.J., Cochrane C.G., Ye R.D. et al. Lipopolysaccharide binding protein expression in primary human hepatocytes and HepG2 hepatoma cells. J Biol Chem 1994; 269: 8477-8482.